Dynamic Contrast-Enhanced Perfusion MR Imaging Measurements of Endothelial Permeability: Differentiation between Atypical and Typical Meningiomas

References

1. ↵
   Jellinger K, Slowik F. Histological subtypes and prognostic problems in meningiomas. J Neurol 1975;208:279–298

   CrossRefPubMedWeb of Science
2. ↵
   Kleihues P, Cavenee WK ed. Pathology and Genetics of Tumours of the Nervous System. Lyon, France: IARC Press;2000
3. ↵
   McLean CA, Jolley D, Cukier E, et al. Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 1993;23:349–353

   PubMedWeb of Science
4. ↵
   Mahmood A, Caccamo DV, Tomecek FJ, et al. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 1993;33:955–963

   PubMedWeb of Science
5. ↵
   Carpeggiani P, Crisi G, Trevisan C. MRI of intracranial meningiomas: correlations with histology and physical consistency. Neuroradiology 1993;35:532–536

   CrossRefPubMed
6. ↵
   Brainard JA, Prayson RA, Barnett GH. Frozen section evaluation of stereotactic brain biopsies: diagnostic yield at the stereotactic target position in 188 cases. Arch Pathol Lab Med 1997;121:481–484

   PubMed
7. ↵
   Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 1998;82:1749–1755

   CrossRefPubMedWeb of Science
8. ↵
   Perry A, Scheithauer BW, Stafford SL, et al. “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999;85:2046–2056

   PubMedWeb of Science
9. ↵
   Perry A, Stafford SL, Scheithauer BW, et al. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 1997;21:1455–1465

   CrossRefPubMedWeb of Science
10. Maier H, Ofner D, Hittmair A, et al. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 1992;77:616–623

    PubMedWeb of Science
11. ↵
    Kolles H, Niedermayer I, Schmitt C, et al. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir 1995;137:174–181
12. ↵
    Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

    PubMedWeb of Science
13. ↵
    Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–798

    CrossRefPubMedWeb of Science
14. ↵
    Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Res Med 1990;14:249–265

    PubMedWeb of Science
15. ↵
    Johnson G, Wetzel S, Cha S, et al. Simultaneous measurement of blood volume and vascular transfer constant by first pass pharmacokinetic modeling. In: Proceedings of the International Society for Magnetic Resonance in Medicine. Berkeley, CA: International Society for Magnetic Resonance in Medicine;2002
16. ↵
    Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797–803

    CrossRefPubMedWeb of Science
17. ↵
    Wilson CB. Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment: the Richard C. Schneider Lecture. J Neurosurg 1994;81:666–675

    PubMedWeb of Science
18. ↵
    Miralbell R, Linggood RM, de la Monte S, et al. The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 1992;13:157–164

    PubMed
19. Barbaro NM, Gutin PH, Wilson CB, et al. Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 1987;20:525–528

    PubMedWeb of Science
20. ↵
    Taylor BW, Jr., Marcus RB, Jr., Friedman WA, et al. The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1988;15:299–304

    CrossRefPubMedWeb of Science
21. ↵
    Milosevic MF, Frost PJ, Laperriere NJ, et al. Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 1996;34:817–822

    CrossRefPubMed
22. ↵
    Zhu F, Zhou Y, Wang C, et al. Perfusion MRI evaluation of correlating perfusion constants with histologic findings in meningiomas. In: Proceedings of the International Society for Magnetic Resonance in Medicine. Berkeley, CA: International Society for Magnetic Resonance in Medicine;2002
23. ↵
    Uematsu H, Maeda M, Sadato N, et al. Vascular permeability: quantitative measurement with double-echo dynamic MR imaging-theory and clinical application. Radiology 2000;214:912–917

    PubMed
24. ↵
    Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91–101

    CrossRefPubMedWeb of Science
25. ↵
    Ikushima I, Korogi Y, Kuratsu J, et al. Dynamic MRI of meningiomas and schwannomas: is differential diagnosis possible? Neuroradiology 1997;39:633–638

    CrossRefPubMed
26. ↵
    Long DM. Vascular ultrastructure in human meningiomas and schwannomas. J Neurosurg 1973;38:409–419

    PubMedWeb of Science
27. ↵
    Dvorak HF, Nagy JA, Feng D, et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999;237:97–132

    PubMedWeb of Science
28. Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711–716

    CrossRefPubMedWeb of Science
29. ↵
    Roberts HC, Roberts TP, Brasch RC, et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;21:891–899

    Abstract/FREE Full Text